KT&G Unveils Duty-Free Exclusive Cigarette Line 'Raison Ionia' in Three Flavors

Nov.18.2024
KT&G Unveils Duty-Free Exclusive Cigarette Line 'Raison Ionia' in Three Flavors
KT&G launches the airport-exclusive "raison ionia" series, available in duty-free stores with three low-tar, low-nicotine flavors. the brand director states their commitment to introducing products reflecting diverse consumer needs.

According to a report by N.News on November 18th, Korean Tobacco (KT&G) announced the official launch of three new products designed specifically for duty-free shops called "Raison ionia" on the 18th.

 

According to reports, the "Raison ionia" series of cigarettes contains 4% tobacco leaf, and its packaging design is based on the "R platform," effectively showcasing the brand's uniqueness. The three new products released are Mystic Purple, Ocean Blue, and Summer Red, each with tar and nicotine content of 0.1mg and 0.01mg. These products can be purchased at duty-free stores in six airports including Incheon, Gimpo, Gimhae, Daegu, and Jeju.

 

KT&G's domestic brand manager Song Seung-Chul said: "In order to provide airport consumers with a special experience, we are launching three duty-free exclusive products called "Raison ionia". In the future, we will continue to enhance brand satisfaction by offering products that reflect diverse consumer needs and trends."

 

KT&G released a limited edition product called "RAISON ionia 3 in 1" in September this year, which includes three new varieties in one pack.

 

U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
Haypp Group said ZYN ULTRA became available nationwide in the United States on June 15 through its e-commerce platforms Nicokick.com and Northerner.com for verified adult nicotine consumers.
Jun.17
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
According to Chinese patent records, a “nicotine tooth patch” application filed by China Tobacco Hubei Industrial Corporation (CTHB) and Hubei Xinye Tobacco Sheet Development Co., Ltd. was published on May 19, 2026. The filing proposes a nicotine gel patch that adheres to the tooth surface, especially the lingual side, to reduce displacement, foreign-body sensation, and accidental swallowing risks associated with existing oral nicotine products.
Jun.10
 Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure
Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure
The Washington Examiner published an opinion article by Tricia McLaughlin, former Assistant Secretary for Public Affairs and spokesperson at the U.S. Department of Homeland Security, arguing that the Trump administration is strengthening enforcement against illegal vape supply chains through the FDA, CBP, and DHS.
Regulations
May.25
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
Philip Morris Korea has officially launched its VEEV e-vapor brand in South Korea, introducing both the VEEV inPRIME device and VEEBI inPRIME pods. The launch further expands PMI’s smoke-free portfolio in Korea, alongside its IQOS heated tobacco products and ZYN nicotine pouches.
Jun.16
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18